| |
|
|
|
Corbus Pharma  
|
|
1.505 -0.135 (-0.08%) |
09-23 16:00 |
|
Open: |
1.65 |
Pre close: |
1.64 |
Target:
|
7.72 
|
|
High: |
1.66 |
Low: |
1.47 |
Resistance:
|
6.61
9.78
|
|
Volume: |
6,913,193 |
Market Cap: |
123M |
Support:
|
1.47
1.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.75
|
MACD |
MACD(12,26):
|
-1.62  |
|
MA(20): |
4.80 |
Signal(12,26,9): |
-1.34 |
|
MA(100): |
6.76 |
Stochastic Oscillator |
%K(14,3):
|
0.43 |
|
MA(250): |
5.91 |
%D(3): |
0.88 |
|
Average Volume(K) |
3-Month: |
393386
|
52-Week |
High:
|
9.78 |
|
10-Days: |
880274 |
Low: |
1.47 |
|
RSI |
RSI(14):
|
20.91 |
Change(%): |
-70.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.695 |
Return on Equity (ttm) |
-240.4 |
Shares Out. (M) |
81.71 |
|
EPS Est. Current Year |
-0.640 |
Return on Assets (ttm) |
-82.5 |
Shares Float (M) |
73.07 |
|
EPS Est. Next Year |
-0.680 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.93 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-99.0 |
% Held by Institutions |
41.18 |
|
Forward EPS |
-1.120 |
Gross Profit (p.s.) |
-0.654 |
Shares Short (K) |
15640 |
|
Book Value (p.s.) |
0.600 |
EBITDA (p.s.) |
-1.459 |
P/E |
-0.89 |
|
Sales Per Share |
0.088 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-93.86 |
P/S |
17.06 |
|
Operating Margin |
-1668.27 |
Levered Free Cash Flow
(M) |
-74.23 |
P/CF |
-1.31 |
|
|
|
|
|
|
